Loading…
The failure of gastroenterologists to apply intestinal ultrasound in inflammatory bowel disease in the A sia‐ P acific: A need for action
Intestinal ultrasound ( IUS ) is a cheap, noninvasive, risk‐free procedure that is significantly underutilized in the diagnosis and management of patients with inflammatory bowel disease ( IBD ) in the A sia‐ P acific region. More cost‐effective methods of monitoring disease activity are required in...
Saved in:
Published in: | Journal of gastroenterology and hepatology 2015-03, Vol.30 (3), p.446-452 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Intestinal ultrasound (
IUS
) is a cheap, noninvasive, risk‐free procedure that is significantly underutilized in the diagnosis and management of patients with inflammatory bowel disease (
IBD
) in the
A
sia‐
P
acific region. More cost‐effective methods of monitoring disease activity are required in light of the increasing global burden of
IBD
(especially in
A
sia), the advent of personalized medicine, and the rising cost of healthcare.
IUS
is a prime example of a technique that meets these needs. Its common clinical applications include assessing the activity and complications of
IBD
. In continental
E
urope, countries such as
G
ermany and
I
taly use this imaging tool as the standard of care and have integrated it into management protocols. There are formal training programs in these countries to train gastroenterologists in
IUS
, and it is used in an outpatient setting during patient consultations. Barriers to its use in the
A
sia‐
P
acific region include lack of experience and research data, and there are few established centers with active training programs. These concerns can be addressed by investing more in
IUS
service provision and by increasing allocation of resources toward local research and training. Increased uptake of
IUS
will ultimately benefit patients with
IBD
. |
---|---|
ISSN: | 0815-9319 1440-1746 |
DOI: | 10.1111/jgh.12871 |